Enestxtnd: Impact of nilotinib dose re-escalation in patients (PTS) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP)

The requested reference [d154890cd9bf906856d548ffd472a5fbb6559730] no longer exists in our database. It has been replaced by the current reference: [389e7887e47a2fd0ff215abe09cc2195b198ca4b]

Authors
Category Primary study
JournalBlood
Year 2013
This article has no abstract
Epistemonikos ID: 779bdad7fe9cfd06f6b49cd9db740edd3adf5686
First added on: Feb 05, 2025